Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases

dc.contributor.authorGonzález-Medina M.ca
dc.contributor.authorCurto-Barredo, Laiaca
dc.contributor.authorLabrador-Horrillo, Moisésca
dc.contributor.authorGiménez Arnau, Anna Mariaca
dc.date.accessioned2018-01-25T10:30:04Z
dc.date.issued2017
dc.format.mimetypeapplication/pdf
dc.identifier.citationGonzález-Medina M, Curto-Barredo L, Labrador-Horrillo M, Giménez-Arnau A. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases. J Eur Acad Dermatol Venereol. 2017 May;31(5):e245-e246. DOI: 10.1111/jdv.14034
dc.identifier.doihttp://dx.doi.org/10.1111/jdv.14034
dc.identifier.issn0926-9959
dc.identifier.urihttp://hdl.handle.net/10230/33747
dc.language.isoeng
dc.publisherWileyca
dc.relation.ispartofJournal of the European Academy of Dermatology and Venereology. 2017 May;31(5):e245-6
dc.rightsThis is the peer reviewed version of the following article: onzález-Medina M, Curto-Barredo L, Labrador-Horrillo M, Giménez-Arnau A. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases. J Eur Acad Dermatol Venereol. 2017 May;31(5):e245-e246, which has been published in final form at http://dx.doi.org/10.1111/jdv.14034. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.keywordOmalizumab
dc.subject.otherUrticària
dc.subject.otherEmbaràs -- Complicacions
dc.titleOmalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two casesca
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
gonzalez-jea-omal.pdf
Size:
87.52 KB
Format:
Adobe Portable Document Format